| Serial Number | 90171690 |
| Word Mark | OPERA |
| Filing Date | Thursday, September 10, 2020 |
| Status | 734 - FIFTH EXTENSION - GRANTED |
| Status Date | Wednesday, November 29, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 13, 2021 |
| Goods and Services | Custom manufacture of oligonucleotides or RNAs for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders |
| Goods and Services | Oligonucleotide compounds being a component in pharmaceutical preparations for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; RNA compounds being a component in pharmaceutical preparations for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; RNA therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Nucleic acid therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Oligonucleotide compounds being a component in pharmaceutical preparations for use in RNA editing; Oligonucleotide compounds being a component in pharmaceutical preparations for use in base editing; Oligonucleotide compounds being a component in pharmaceutical preparations for use as RNA therapeutic for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Oligonucleotide compounds that facilitate the editing of RNA base; Pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; pharmaceuticals, namely, bio-pharmaceutical preparations for the treatment of rare diseases |
| Goods and Services | Research and development of pharmaceutical products; research and development in the field of bioscience; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders; research and development of pharmaceutical preparations for the treatment of liver-based disorders, eye disorders and CNS disorders; research and development of oligonucleotide compounds for targeted RNA editing; research and development of oligonucleotide drug platforms for use in the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 16, 2020 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 16, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 16, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Korro Bio, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Party Name | Korro Bio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Event Date | Event Description |
| Monday, September 14, 2020 | NEW APPLICATION ENTERED |
| Friday, October 16, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 21, 2021 | ASSIGNED TO EXAMINER |
| Thursday, January 28, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, January 28, 2021 | NON-FINAL ACTION E-MAILED |
| Thursday, January 28, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 9, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 9, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 9, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 9, 2021 | ASSIGNED TO LIE |
| Tuesday, March 9, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, March 9, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 10, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 10, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 11, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 24, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 13, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 13, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 8, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 30, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 30, 2021 | SOU EXTENSION 1 FILED |
| Tuesday, November 30, 2021 | SOU EXTENSION 1 GRANTED |
| Thursday, December 2, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 3, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, June 3, 2022 | SOU EXTENSION 2 FILED |
| Friday, June 3, 2022 | SOU EXTENSION 2 GRANTED |
| Tuesday, June 7, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, November 28, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, November 28, 2022 | SOU EXTENSION 3 FILED |
| Monday, November 28, 2022 | SOU EXTENSION 3 GRANTED |
| Wednesday, November 30, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 25, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, May 25, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, May 25, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, May 31, 2023 | SOU EXTENSION 4 FILED |
| Wednesday, May 31, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 31, 2023 | SOU EXTENSION 4 GRANTED |
| Friday, June 2, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, November 29, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 29, 2023 | SOU EXTENSION 5 FILED |
| Wednesday, November 29, 2023 | SOU EXTENSION 5 GRANTED |
| Thursday, November 30, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 7, 2024 | TEAS STATEMENT OF USE RECEIVED |